Reata Pharmaceuticals to Present Data from Pivotal Phase 2b Trial in Type 2 Diabetics With Chronic Kidney Disease - Drugs.com MedNews
Links shared publicly online about this topic.
- 734total visits
Reata Pharmaceuticals to Present Data from Pivotal Phase 2b Trial in Type 2 Diabetics With Chronic Kidney Disease - Drugs.com MedNews
View full resource at drugs.com
Tags: Diabetes, Kidney Health, Urinary System, End-Stage Renal Disease, Drug, Pharma, Chronic Kidney Disease
Most Recently Shared on November 11, 2010 at 10:04 pm By:
Reata Pharmaceuticals to Present Data from Pivotal Phase 2b Trial in Type 2 Diabetics With Chronic Kidney ... http://bit.ly/aRP5bR #drug
Reata Pharmaceuticals To Present Data From Pivotal Phase 2b Trial In Type 2 Diabetics With Chronic Kidney Disease | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com
keyvive.com — “Reata Pharmaceuticals To Present Data From Pivotal Phase 2b Trial In Type 2 Diabetics With Chronic Kidney Disease | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com” View full resource at keyvive.com
Most Recently Shared on November 12, 2010 at 8:34 pm By:
Reata Pharmaceuticals To Present Data From Pivotal Phase 2b Trial In Type 2 Diabetics With… http://goo.gl/fb/WWHFj
Reata Pharmaceuticals To Present Data From Pivotal Phase 2b Trial In Type 2 Diabetics With Chronic Kidney Disease
medicalnewstoday.com — “Reata Pharmaceuticals announced that the company will present data on the primary endpoint from a pivotal Phase 2b clinical trial of bardoxolone methyl in patients with chronic kidney disease (CKD” View full resource at medicalnewstoday.com
Most Recently Shared on November 12, 2010 at 6:05 pm By:
MNT Clinical Trials Health News
Reata Pharmaceuticals To Present Data From Pivotal Phase 2b Trial In Type 2 Diabetics With Chronic Kidney Disease http://mnt.to/3Mvr
Reata to present bardoxolone methyl Phase 2b clinical trial data for CKD, type 2 diabetes at ASN Conference
news-medical.net — “Reata Pharmaceuticals today announced that the company will present data on the primary endpoint from a pivotal Phase 2b clinical trial of bardoxolone methyl in patients with chronic kidney disease (CKD) and type 2 diabetes. The data will be presented in a late-breaking oral presentation at the American Society of Nephrology (ASN) Renal Week Conference to be held November 16-21, 2010, in Denver, Colorado.” View full resource at news-medical.net
Most Recently Shared on November 12, 2010 at 7:59 am By:
Reata to present bardoxolone methyl Phase 2b clinical trial data for CKD, type 2 diabetes at ASN Conference: Rea... http://bit.ly/bIR6WV
Advertisement
